TAK-071

SynDRA canonical compound SYN0040003 — structure-anchored drug synonym record

Clinical phase	Phase 2
Primary target(s)	FOS \| SNCA
Mechanism of action	mitotic inhibitor
Indication	parkinson's disease
Disease area	neurology/psychiatry

All known targets

CHRM1
FOS
SNCA

Mechanisms of action (all sources)

CHRM1 POSITIVE ALLOSTERIC MODULATOR
Muscarinic acetylcholine receptor M1 positive allosteric modulator
mitotic inhibitor
CHRM1 MODULATOR

Drug classes

Muscarinic Agonists

Cross-references

PubChem CID: 92042879
ChEMBL: CHEMBL4594351
DrugBank: DB18954
TTD: D09BBA

Synonyms

WFSARWQASFQZMG-FGZHOGPDSA-N
RefChem:187180
UNII-59XC9G796Y
orb1309039
SCHEMBL17201222
SCHEMBL29362199
GTPL12302
WFSARWQASFQZMG-VXKWHMMOSA-N
TAK-071?
EX-A12361
AKOS040739717
AC-31580
DA-78167
MS-27399
HY-122190
CS-0082523
D77973
T13066

Look up TAK-071 in the interactive SynDRA portal →